Introduction
Ovarian cancer is the third most common gynecological malignancy globally, with a five-year survival rate of 40–45%.1–3 Cytoreductive surgery serves as the first-line treatment for ovarian cancer and requires multi-organ…
Ovarian cancer is the third most common gynecological malignancy globally, with a five-year survival rate of 40–45%.1–3 Cytoreductive surgery serves as the first-line treatment for ovarian cancer and requires multi-organ…